Related Experiment Videos
Negative cervical smears before CIN 3/carcinoma. Reevaluation with the PAPNET Testing System
H Doornewaard1, H van de Seijp, J M Woudt
1Department of Pathology, Utrecht University, The Netherlands.
Acta Cytologica
|January 1, 1997
Summary
The PAPNET testing system effectively identifies false negative cervical smears. This advanced tool aids in reducing the false negative rate when used alongside conventional screening methods for cervical cancer.
Area of Science:
- Gynecologic Oncology
- Cytopathology
- Medical Technology
Background:
- Cervical cancer screening relies on accurate cytologic smear analysis.
- False negative results in cervical cytology can lead to delayed diagnosis and treatment.
- Advanced automated systems are being developed to improve screening accuracy.
Purpose of the Study:
- To evaluate the PAPNET testing system's efficacy in detecting false negative cervical smears.
- To assess the system's ability to identify high-grade lesions and cervical cancer missed by initial review.
Main Methods:
- Archival cervical cytologic smears from women with confirmed high-grade lesions or cervical cancer were analyzed.
- Forty-six negative smears from cases that later developed high-grade lesions (CIN 3) or carcinoma were tested.
- Smears were processed using the PAPNET system, with positive findings reviewed by a cytotechnologist.
Main Results:
- The PAPNET system identified 9 out of 46 (20%) false negative smears.
- These reclassified smears included low-grade and high-grade squamous intraepithelial lesions (SIL).
- In control groups, PAPNET detected 1.6% of previously unrecognized positive cases.
Conclusions:
- The PAPNET testing system demonstrates significant potential for detecting false negative cervical smears.
- Its use as an adjunct to conventional screening can substantially reduce the false negative rate.
- PAPNET offers a valuable tool for enhancing the sensitivity of cervical cancer screening programs.